![Lode Debrabandere](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lode Debrabandere
Director/Miembro de la Junta en Prolexys Pharmaceuticals, Inc. .
Cargos activos de Lode Debrabandere
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Prolexys Pharmaceuticals, Inc.
![]() Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Director/Miembro de la Junta | - | - |
Historial de carrera de Lode Debrabandere
Antiguos cargos conocidos de Lode Debrabandere.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ELUTIA INC. | Director/Miembro de la Junta | - | 04/06/2018 |
Director Ejecutivo | - | 04/06/2018 | |
Presidente | - | 04/06/2018 | |
OSIRIS THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/07/2006 | 03/02/2016 |
Director Ejecutivo | 02/12/2013 | 03/02/2016 | |
Director de Operaciones | 26/10/2012 | 01/11/2013 | |
Corporate Officer/Principal | 01/07/2006 | 26/10/2012 | |
Presidente | 02/12/2013 | 03/02/2016 | |
BRISTOL-MYERS SQUIBB COMPANY | Ventas & Marketing | - | - |
Formación de Lode Debrabandere.
Katholieke Universiteit Leuven | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Bélgica | 2 |
Operativa
Director/Board Member | 3 |
Chief Executive Officer | 2 |
President | 2 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ELUTIA INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Osiris Therapeutics, Inc.
![]() Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
Prolexys Pharmaceuticals, Inc.
![]() Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Health Technology |
- Bolsa de valores
- Insiders
- Lode Debrabandere
- Experiencia